Ultragenyx Pharmaceutical (RARE) Net earnings per share (EPS TTM)

RARE (Ultragenyx Corp) - company brandmark

Ultragenyx Pharmaceutical (RARE) is optimizing its development by outsourcing drug manufacturing and testing to third-party contractors. This chart of the annual EPS TTM captures the impact of such a strategy on profitability, where -5.21 serves as the final level marker. A stable team of scientists maintains the brand's ethics, yet revenue deficits and R&D expenses are leading to the depletion of reserves and a search for external financing.

RARE ultragenyx.com Earnings per share for the last 12 months (07/04/2022 - 11/18/2026)

Financial and market metric breakdowns for Ultragenyx Pharmaceutical (RARE)

- stock price and consensus target price:
General company analysis:RARE - Ultragenyx Pharmaceutical
Flagship merchandise of Ultragenyx Corp

For the biotechnology sector of Ultragenyx Pharmaceutical (RARE), where Crysvita revenue growth and FDA approvals drive capitalization, this indicator serves as a measure of real efficiency in generating earnings per share. By analyzing the rolling year net income per share, an investor sees smoothed profitability trends without the influence of one-off reports, allowing for an objective assessment of the company's potential as an M&A target.

Key competitors

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|BEAM (Beam Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SRPT (Sarepta Therapeutics Inc)|Net earnings per share for the last four quarters Twist Bio (TWST)|TXG: Net earnings per share for the last 12 months|Earnings per share for the trailing year NTLA (Intellia Therapeutics)|Stoke Therapeutics (STOK) - Earnings per share for the last twelve months|BioLife Corp (BLFS) - Net earnings per share (EPS TTM)|WVE (wavelifesciences.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Maze Therapeutics Inc|Net earnings per share (EPS TTM) SION|PRME - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) TSHA (Taysha Corp)|Earnings per share for the trailing year QURE|MeiraGTx Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year REGENXBIO Corp (RGNX)|solidbio.com (SLDB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OCGN|PACB (PacBio Corp) - Net earnings per share (EPS TTM)|BNTC: Earnings per share for the trailing year|Earnings per share for the last twelve months Design Corp (DSGN)|Net earnings per share for the last 12 months Rocket Pharmaceuticals Inc RCKT|FDMT: Net earnings per one share for the last twelve months|LXEO: Earnings per share for the last 12 months|Korro Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Editas Medicine|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)